Jefferies Cuts Price target on Auris Medical Holding (EARS) Following 4Q

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Jefferies Cuts Price target on Auris Medical Holding (EARS) Following 4Q

Auris Medical Holding (EARS) Reports Q4 Loss of CHF0.16/Share

March 14, 2016 6:36 AM EDT

Auris Medical Holding (NASDAQ: EARS) reported Q4 EPS of (CHF0.16), versus (CHF0.17) reported last year.

"We achieved significant progress with our development programs in 2015, bringing us closer to the completion of the pivotal AM-101 tinnitus trials and advancing the late-stage AM-111 hearing loss program," commented Thomas Meyer, Auris Medical's founder, Chairman and Chief Executive Officer. "We look forward to the upcoming results of our Phase 3 AM-101 program, initiating the second of our Phase 3 AM-111 trials and attaining further progress towards our ultimate goal of providing effective and safe inner ear therapeutics for... More

Trading Radar for 3/14: 3D Systems (DDD), MannKind (MNKD), A.M. Castle (CAS), Partner Communications (PTNR) Report

March 11, 2016 3:30 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

3D Systems (NYSE: DDD) - consensus EPS $0.03
A.M. Castle & Co. (NYSE: CAS) - no Street consensus
Auris Medical Holding (Nasdaq: EARS) - consensus loss $0.28
Biospecifics Technologies (Nasdaq:... More